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ABSTRACT 
Based on carbamazepine's hypothesized ability to stabilize temporal lobe seizures and 
behavioral disorders and its ability to inhibit limbic system excitability in models such as kindling, we 
undertook this study with the aims of finding out the response of carbamazepine in kindler and non 
kindler groups and to see the relationship of socio-demographic and clinical variables in kindler and 
non-kindler bipolar mood disorder with response to carbamazepine. Simple random sampling was 
done and patients (over a period of one and a half year) between 18-50 years who had a diagnosis of 
Bipolar Affective Disorder, current episode mania as perlCD-10 and who had history of at least 
three manic or depressive episode in the past were taken. The total sample was divided into two 
groups i. e. kindler and non-kindlers. Kindlers were defined as patients with 3 or more affective episodes 
in less than equal to 1 year apart. Non-kindlers were defined as patients with at least 3 episodes in the 
past with inter episodic period of more than 1 year. All the patients included in this study were followed 
up for 6 months and were given carbamazepine in adequate dosages. Fifty -five patients completed 
the 6 months follow up. Results showed that there was no significant difference between the two 
groups based on sex, past history of substance intake, type of mood (irritable versus elated), number 
of relapses during the follow-up and improvement on carbamazepine. Our study does not support the 
kindling hypothesis. 
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Neuropsychiatric theories about bipolar 
disorders have emphasized models of kindled 
limbic system activity as a possible mechanism 
to explain recurrent phases of illness. In this 
paradigm, it is hypothesized that regular, frequent 
period of early affective illness may trigger more 
subsequent episodes via an excitatory 
mechanism analogous to that seen in seizure 
disorders (Post et al., 1986; Post and Weiss, 
1992). 
According to Posfs theory (Post et al 1986, 
Post, 1992), affective symptoms both within and 
between episodes are thought to have a kindling 
or sensitization effect with progressively lower 
thresholds for new episodes. As advanced by Post 
(Post & Weiss, 1989), this theory builds on the 
physiological finding that intermittent sub threshold 
electrical or chemical stimuli produce increasing 
strong neuronal depolarization of the brain, a 
process of sensitization that may possess 
temporal similarities to the episodic behavior 
disturbances of bipolar disorder. 
Several studies have described a 
shortening of cycle lengths over the course of the 
illness(Cutler& Post 1985; Roy Byrne etal, 1985; 
Kessingetal. 1998). 
Several such studies involving patients with 
bipolar disorder were consistent with kindling 
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(Ambelas 1979; Dunneretal., 1977; Goldberg and 
Harrow 1994; Gitlin et al 1995; Kessing et al 
1998), whereas others did not support (Turvey et 
al 1998), or were indeterminate (Winokur et al 
1993). 
But, the studies supporting the kindling 
hypothesis are not so strong from methodological 
point of view. 
First the initial episode of mania is difficult 
to reliably locate in time, particularly in 
retrospective studies relying on patients' 
recollection (Ambelas 1979). Second, 
assessment of life events vary from study to study, 
ranging from standardized interview to clinical 
observation, to chart review (Kessing et al. 1998) 
and again often are limited by over reliance of 
patient's self-report. Thirdly, life events may be 
cause or consequence of bipolar disorder and if 
studies would find as many or even more life events 
in later as in earlier episodes, it does not support 
the kindling hypothesis and also hospitalization 
data are the basis for a number of studies; the 
methodology captures severe but not the mild 
episodes which may make the result relevant for 
severe but not mild form of bipolar illness. 
The newest data derived from a well 
designed prospective study of course of bipolar 
disorder as a part of the NIMH collaboration study 
of depression (Turvey et al., 1998) in which 165 
patients with type I bipolar disorder or 
schizoaffective disorder mainly affective type were 
followed prospectively for about 7 years, reveal 
no evidence of a shortening of cycle length with 
time. Instead poor prognosis was associated with 
polyphasic (change of polarity in the same 
episode) episodes Roy Byrne et al. (1985) and 
Maj et al. (1995) also reported association 
between switching and higher relapse rates. These 
findings suggest that polyphasic episodes are a 
common clinical presentation of poor prognosis 
in bipolar I disorder. 
Dunner et al.(1974) first coined the term 
rapid cycling in a land mark paper that summarized 
longitudinal data designed to evaluate clinical 
factors associated with the failure of lithium 
prophylaxis. When the study results were 
analyzed according to cycle frequency, a 
disproportionate percentage of rapid cyclers were 
noted in the lithium failure group (82% rapid cycler 
failure compared to 41% failures in the classic 
group). 
Numerous studies have proven the efficacy 
of carbamazepine in bipolar mood disorders, 
especially so in rapid cyclers (Post et al., 1983), 
either as a single drug or in combination with 
lithium or neuroleptics 
Postetal. (1987) studied 19 acutely manic 
patients in a double blind trial of carbamazepine 
in doses averaging 1240 mg per day. The blood 
level of carbamazepine was 10.4± 2.2 pg/ml. The 
preliminary data suggested that several predictors 
of poor response to lithium (manic severity, 
dyphoria, rapid cycling and negative family history) 
might be associated with good antimanic response 
to carbamazepine. 
Placidi etal. (1986) studied the comparative 
efficacy of carbamazepine versus lithium in 83 
bipolar patients and followed for 3 years. The 
respective indices of relapse per group did not 
differ significantly. It was concluded that lithium 
salt might be more efficacious in 'classical' affective 
disorder (i..e. major recurrent depression, bipolar 
disorder with mood congruent features) whereas 
carbamazepine is more effective in the treatment 
of other group (bipolar psychosis with mood 
incongruent features, schizoaffective disorder or 
schizophreniform disorder). 
Greil et al (1998) in a randomized, 
prospective, multicenter study (N= 67) with an 
observation period of 2.5 years reached similar 
conclusions. 
Based an carbamazepine's hypothesized 
ability to stabilize temporal lobe seizures and 
behavioral disorders and its ability to inhibit limbic 
system excitability in models such as kindling, 
along with the above mentioned controversial 
literature, we undertook this study with the aims 
of finding out socio-demographic and clinical 
characteristic of patients with kindler and non 
kindler mood disorder, to see the response of 
carbamazepine in kindler and non kindler groups 
and to see the relationship of socio-demographic RESPONSE OF CARBAMAZEPINE- KINDLERS VERSUS NON-K1NDLERS 
^ and clinical variables in kindler and non-kindler 
bipolar mood disorder with response to 
carbamazepine. 
MATERIAL AND METHODS 
The study was conducted at the Central 
Institute of Psychiatry, Kanke, Ranchi (643 bedded 
hospital, about 150,000 outpatients and 1800 
admissions per year) 
The present study had a prospective design. 
Simple random sampling was done and patients 
(over a period of one and a half year) between 18-
50 years who had a diagnosis of bipolar affective 
disorder, current episode mania, with or without 
psychotic features as per ICD -10 (WHO 1992) 
and who had history of at least 3 manic or 
depressive episode in the past were taken. 
Putative kindling was operationally defined 
for patients with three or more preindex episodes 
less than or equal to one year apart. Kindlers were 
compared to bipolars with preindex episodes 
greater than one year apart (Goldberg and Harrow, 
1994). 
Exclusion Criteria were any other axis I and 
axis II diagnosis, and clinical evidence of organic, 
substance induced disorder, neurological disorder 
and mental retardation. 
Within 48 hours of the admission, the 
patient and key relatives were interviewed on 
socio-demographic and clinical data sheet to 
gather information. 
All the patients included in this study were 
evaluated on Brief Psychiatric Rating Scale 
(BPRS) to capture the type of psychopathology 
that is affected by drug treatment, Young's Mania 
Rating Scale (YMRS) to assess the resolution of 
symptoms of mania, and Hamilton Depression 
Rating Scale (HDRS) to assess the development 
of depressive episode during the treatment period-
at 0 hours (Within 48 hours of admission), 2 and 
4 weeks during admission and also at 3 months 
and 6 months during follow up after discharge. 
All the patient included in this study were given 
carbamazepine in adequate dosages. Exact 
dosing of carbamazepine and other drugs like anti 
psychotics and hypnotics was left to the treating 
team. 
Chi-square test was employed for analysing 
categorical data, while t test and paired t test were 
used for analysis of continuous data. 
RESULTS 
Initially 66 patients were taken for the study. 
Out of this 55 patients completed the 6 months 
follow up and rest 11 patient did not come for follow 
up after being discharged from the hospital. The 
drop out at 3 months was same as that at 6 
months i.e. 11 patients. 
TABLE 1 
SOCIODEMOGRAPHIC AND CLINICAL PROFILES OF 
KINDLER AND NON-KINDLER GROUP (FOR CONTINUOUS 
DATA) 
Variable Group 
Kindler Non Kindler t 
N=38 N=28 value 
Mean± SD Mean± SD 
Age 32.10±9.75 35.57±8.88 t=1.48 
Number of past 7.47±3.62 4.78±3.48 t=3.03* 
episodes 
episodes Dose 718*108.69 728±124.29 t=0 35 
ofCBZ 
Duration of illness 43 21 ±58 69 48±35.43 t=1.66 
d.f. for all comparison-64, * p<0.01 
The dose of carbamazepine was 718 mg 
(± 108.69) for kindler group and 728 mg (± 124.29) 
for non-kindler group. No significant difference was 
found between the two groups in doses(Table I). 
In the sample, the number of past episodes 
was 7.47 (± 3.62) in kindler group and 4.78 (± 
3.48) among non-kindler group and significant 
difference (p < .05) was found between the two 
groups(Table I). There was no significant difference 
in age and duration of illness amongst the two 
groups 
There were 84% males and 15% females 
in the kindler group and 85% males and 14% 
females in the non-kindler group(Table II). 
Results show that both groups were simi-
lar in respect to marital status, occupation, domi-
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cile, past history of psychiatric illness, type of 
medication used {antipsychotics and benzodi-
azepines}, relapse to mania / depression, history 
of substance use and type of mood (Table II). 
TABLE 2 
SOCIO-DEMOGRAPHIC AND CLINICAL PROFILES OF 
KINDLER AND NON-KINDLER GROUPS (FOR 
TABLE 3 
COMPARISON OF TREATMENT RESPONSE DURING 
FOLLOW-UPS FOR KINDLER AND NON KINDLER PATIENT 
ON BPRS SCORE 
' Groupsi 
Variable Kindler Non Kindler 
groups groups 
(N =30) (N = 25) 
CATEGORICAL DATA) 
Variable 
sex 
Male 
Female 
Marital 
Married 
Unmarried 
Occupation 
House wife 
Job 
Farmer 
Student 
Residence 
Rural 
Urban 
Past historv 
Mania 
Mania + 
depression 
Familv history 
Absent 
Present 
Group 
Kindler 
n 
32 
6 
28 
10 
7 
4 
23 
4 
25 
13 
24 
14 
19 
19 
Tvoe of Medication 
CBZ+ 
Benzodiazepine 
CBZ + 
Antipsychotic 
Relapse to manii 
Relapse to 
depression 
11 
27 
a 4 
1 
Substance history 
Absent 
Present 
Mood 
Elation 
Irritable 
25 
13 
37 
1 
(%) 
(84.2) 
(15.8) 
(73.7) 
(26.3) 
(18.4) 
(10.5) 
(60.5) 
(10.5) 
(65.8) 
(34.2) 
(63.2) 
(36.8) 
(50) 
(50) 
(28.9) 
(71.1) 
(13.3) 
(33) 
(65.8) 
(34.2) 
(97.4) 
(2.6) 
Non kindler 
n 
24 
4 
24 
4 
3 
4 
18 
3 
18 
10 
17 
11 
15 
13 
9 
19 
1 
3 
21 
7 
24 
4 
(%) 
(85.7) 
(14.3) 
(85.7) 
(14.3) 
(10.7) 
(14.3) 
(64.3) 
(10.7) 
(64.3) 
(35.7) 
(60.7) 
(39.3) 
(53.6) 
(46.4) 
(32.1) 
(67.9) 
(4) 
(12) 
(75) 
(25) 
(85.7) 
(14.3) 
Chi 
Square 
0.01 
0.77 
0.86 
0.01 
0.01 
0.01 
0.01 
2.72 
0.28 
1.68 
BPRS at 
1st contact 
BPRS at 
2nd week 
BPRS total 
at 1st contact 
Mean ± SD t 
14.23±5.82 9.58* 
6.2±5.03 
14.23±5.82 11.05* 
BPRS at 1 month 3.29±4.23 
BPRS total 
at 1 st contact 
14.23±5.82 10.91* 
BPRS at 3-month 0.66±2.07 
BPRS total 
1st contact 
BPRS at 
6 month 
* p<0.01 
14.23±5.82 10.60* 
1.13±2.94 
TABLE 4 
MeantSD t 
14.68±5.26 9.71* 
7.24±5.31 
14.68*5.26 12.90* 
3.84±5.73 
14.68*5.26 12.68* 
.80*2.02 
1.68*5.26 11.17* 
.72*2.15 
COMPARISON OF TREATMENT RESPONSE DURING 
FOLLOW-UPS FOR KINDLER AND NON KINDLER PATIENT 
S ON YMRS SCORE 
Variable 
YMRS at 
1st contact 
YMRS at 
2nd week 
YMRS total 
Groups 
Kindler 
groups 
(N = 30) 
Mean ± SD t 
24.3±6.49 15.52* 
7.86±5.53 
24.23±6.12 15.90* 
at 1st contact 
YMRS at 1 month 6.23±4.55 
Non Kindler 
groups 
(N = 25) 
Mean±SD t 
22.24*8.01 12.80* 
7.08*5.23 
32.24*8.01 12.12* 
6.4±6.25 
For all comparisons d.f.=1 except occupation where it is 3 
All values of x
: were not significant 
The history of substance intake in the form 
of cannabis and alcohol abuse was found in 34.2% 
of kindler patients and 25% in non-kindler patients 
with no statistically significant difference (Table 
II). 
YMRS total 24.30*6.99 17.23*22.24*8.01 12.40* 
at 1st contact 
YMRS at 3-month 2.76±2.75 2.72*3.52 
YMRS total 24.30*6.49 13.92* 22.24*8.01 12.65* 
1st contact 
YMRS at6month 3.2±4.9 1.8*1.91 
*p<0.01 
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During six months follow up, four patients (13.3%) 
relapsed into mania in the kindler group and one 
patient (4 %) relapsed in to mania among the non-
kindler group. No significant difference between 
the two groups in terms of relapse was found(Table 
II). 
Comparing the total score on BPRS, 
statistically significant reduction of total score was 
found on successive follow-ups with maximum 
reduction in scores at 3 months in both the kindler 
and non-kindler groups (Table III). 
Similarly on YMRS scale significant 
reduction of total score was found on successive 
follow-ups with maximum reduction in scores at 
3 months in both the kindler and non-kindler groups 
(Table IV). 
DISCUSSION 
In the earlier studies the dose of 
carbamazepine was higher in bipolar patients 
(Post et al., 1983; Placidi et al., 1986) than that 
used in our study but this difference might be due 
to different pharmacodynamics and 
pharmacokinetics of the drugs in Indian population. 
We found in our study that the number of past 
episodes in the kindler group was significantly 
greater (p<. 05) than the non-kindler group which 
does not support the previous results by Goldberg 
and Harrow (1994) who did not find any significant 
difference of number of past episodes among 
kindler and non kindlers. But this is in congruence 
with other previous studies (Cutler & Post 1985; 
Roy Byrne etal., 1985; Kessingetal. 1998), which 
suggested shortening of cycle lengths over the 
course of illness. 
We found no statistically significant 
difference in the number of males and females in 
the two groups (kindlers vs. non-kindlers). This 
finding is different from previous studies (Bauer et 
al., 1994, Dunneretal. 1977) where a significantly 
higher proportion of females were found in rapid 
cycler group. The lesser number of female 
patients can be attributed to the social bias against 
seeking psychiatric consultation for the female 
gender in our country. The male is more likely to 
be the wage earner and thus gets immediate 
attention when his wage earning capacity is 
affected (Khanna etal., 1992). 
Our study supports the common co-
morbidity of substance abuse in affective disorder 
patient though there is no significant difference 
amongst the two groups in this aspect. 
Our finding of no significant difference 
between the two groups in terms of relapse does 
not corroborate with Goldberg & Harrow (1994), 
where kindlers had a significantly higher number 
of relapses as compared to non-kindlers on 2 
years and 4.5 years follow-up. 
One reason could be comparatively shorter 
follow up period in current study. None of the 
patient in Goldberg and Harrow's study was on 
anti epileptic mood stabilizer while in current study 
all patient were on anti epileptic mood stabilizer, 
which is of proven efficacy in preventing the relapse 
in kindlers (Postetal. 1992), Furthermore, their 
sample size (N=26) was small in comparison to 
the current study. 
Our results of maximum improvement 
within three months of treatment support the 
previous findings by Placidi et al. (1986) who 
studied 83 bipolar patient on double blind trial of 
carbamazepine and lithium and followed up for 
three years and found that patient showed 
maximum improvement within first three months 
of treatment and then maintained this 
improvement up to 12 months of follow up. 
The phenomenon of three patients changing 
their polarity also supports the previous findings. 
Tohen et al. (1990) followed up seventy-five bipolar 
manic patients for four years. Eleven subjects 
(15%) cycled into depression during the index 
hospitalization within the first two months period. 
As the total population was high (N=66) and total 
score of HDRS was less, mean and standard 
deviation were negligible and because of this it 
could not be discussed. 
Our study does not support the kindling 
hypothesis. The reason behind that may be follow 
up in our study was less in comparison to previous 
studies (Kessing et al. 1998; Goldberg & Harrow, 
1994). Secondly, patients in previous studies got 
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anti depressants during treatment, which is a 
known cause of switching. 
Keeping in mind some of the limitations of 
the present study, a few recommendations for 
future research are in order. Though the sample 
size taken was modest, a larger number of 
patients would give greater significant results. The 
patients should be followed up for long periods of 
time that will give more clear picture of effect of 
drugs. More female patients should be included 
in the study and if both the groups would get only 
carbamazepine in adequate dosages it would give 
more accurate results. Side effect of drugs should 
have been rated. Thyroid status of the patients 
should have been checked biochemically which 
was not done in this study as thyroid 
abnormalities may contribute to rapid cycling.. 
Type of antipsychotics and hypnotics used, and 
their doses should have been controlled for, which 
was not done in the current study. 
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